Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,290 across all filing types
Latest filing 2020-12-21 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
招商证券关于安图生物可转换公司债券2020年持续督导期间现场检查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "现场检查报告" (on-site inspection report) related to the continuous supervision work for a convertible bond issuance by Zhengzhou Antu Bioengineering Co., Ltd. It is issued by the sponsor institution, China Merchants Securities Co., Ltd., and details the findings of an on-site inspection conducted in December 2020. The content covers governance, internal control, information disclosure, independence, use of raised funds, related party transactions, and operational status. It is a detailed report on the regulatory compliance and supervision of the bond issuance process, not a full annual or interim financial report, nor an earnings release or audit report. It is a regulatory compliance and supervisory report related to the bond issuance and ongoing monitoring. Given the nature and content, it fits best under Audit Report / Information (AR), which includes standalone audit or regulatory inspection reports and results of internal or regulatory stress tests, excluding full annual reports. The document length is 2766 characters, which is relatively short but contains substantive inspection findings, not just an announcement or certification. Therefore, the classification is AR with high confidence.
2020-12-21 Chinese
招商证券关于安图生物非公开发行股票2020年持续督导期间现场检查报告
Regulatory Filings
2020-12-21 Chinese
持股5%以上股东减持股份进展公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding the progress of a shareholding reduction by a shareholder holding more than 5% of the company's shares. It details the shareholder's name, shareholding percentage, reduction plan, progress, and related risks. The content focuses on shareholding changes and disclosures related to a significant shareholder's reduction of shares. It does not contain financial statements, management discussion, or other report types. The document fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2020-12-02 Chinese
2020年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2020 second extraordinary shareholders' meeting of Zhengzhou Antu Bioengineering Co., Ltd. It details the meeting date, attendance, voting results on specific proposals, and legal witness statements. The content focuses on the voting outcomes and procedural compliance rather than presenting financial data or detailed reports. The document length is relatively short (1841 characters), and it serves as an official notice of voting results rather than a full report or presentation. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-12-02 Chinese
2020年第二次临时股东大会法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and compliance of the convening, holding, attendance, and voting procedures of the 2020 second extraordinary general meeting of shareholders of Zhengzhou Antu Bioengineering Co., Ltd. It details the meeting's notice, attendance, voting results, and confirms the legality of the meeting process. This is not a financial report, earnings release, or management discussion, but a legal opinion related to a shareholders' meeting. It is not a proxy solicitation or voting results announcement per se, but a legal opinion letter on the meeting's legality. Such legal opinion letters related to shareholder meetings are best classified under Regulatory Filings (RNS) as they do not fit other categories and are regulatory compliance documents.
2020-12-02 Chinese
2020年第二次临时股东大会会议材料
AGM Information Classification · 100% confidence The document is titled as materials for the "2020 Second Extraordinary General Meeting" of Autobio Diagnostics Co., Ltd. It contains detailed agenda items for the shareholders' meeting, including proposals for the use of idle raised funds for cash management and changes to the company's registered capital, business scope, and amendments to the Articles of Association. The content includes meeting procedures, voting methods, legal opinions, and detailed explanations of the proposals to be voted on. There are no financial statements or comprehensive financial data presented, but rather materials prepared for the shareholders' meeting to inform and facilitate voting. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting. The document length is 8322 characters, which is substantive and not a mere announcement or notice. Therefore, the classification is AGM Information (AGM-R).
2020-11-23 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.